Vasoactive intestinal peptide decreases inflammation and tight junction disruption in experimental necrotizing enterocolitis
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Oct 2019 · 1 min read
In brief
In brief
This murine study demonstrates that exogenous vasoactive intestinal peptide (VIP) administration reduces NEC severity by decreasing inflammatory markers (IL-6, TNF-α) and preserving tight junction integrity (Claudin-3). The findings suggest VIP may offer therapeutic benefit in neonatal NEC by mitigating intestinal barrier disruption.
Written by the GCMD Library team from the article.
Background and Purpose
Excessive inflammatory cell infiltration and accumulation in the intestinal mucosa are pathological features of necrotizing enterocolitis (NEC) leading to intestinal barrier disruption. Vasoactive intestinal peptide (VIP) is a potent anti-inflammatory agent that regulates intestinal epithelial barrier homeostasis. We previously demonstrated that VIP-ergic neuron expression is decreased in experimental NEC ileum, and this may be associated with inflammation and barrier compromise. We hypothesize that exogenous VIP administration has a beneficial effect in NEC.
Methods
NEC was induced in C57BL/6 mice by gavage feeding, hypoxia, and lipopolysaccharide administration between postnatal day (P) 5 and 9. There were four studied groups: Control (n = 6): Breast feeding without stress factors; Control + VIP (n = 5): Breast feeding + intraperitoneal VIP injection once a day from P5 to P9; NEC (n = 9): mice exposed to NEC induction; NEC + VIP (n = 9): NEC induction + intraperitoneal VIP injection. Terminal ileum was harvested on P9. NEC severity, intestinal inflammation, (IL-6 and TNFα), and Tight junctions (Claudin-3) were evaluated.
Results
NEC severity and intestinal inflammation were significantly decreased in NEC + VIP compared to NEC. Tight junction expression was significantly increased in NEC + VIP compared to NEC.
Conclusion
VIP administration has a beneficial therapeutic effect in NEC by reducing inflammation and tight junction disruption.